Clonidine
Clonidine is a prescription medication available as transdermal patches in strengths of 0.1 mg/24hr, 0.2 mg/24hr, and 0.3 mg/24hr. It works as a central alpha-2 adrenergic agonist to help lower blood pressure. Manufactured by Dr. Reddy's Laboratories Inc. and Mayne Pharma Inc., it's approved under ANDA079090 for transdermal use. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Clonidine is a prescription medication available as transdermal patches in strengths of 0.1 mg/24hr, 0.2 mg/24hr, and 0.3 mg/24hr. It works as a central alpha-2 adrenergic agonist to help lower blood pressure. Manufactured by Dr. Reddy's Laboratories Inc. and Mayne Pharma Inc., it's approved under ANDA079090 for transdermal use. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Clonidine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Clonidine — ANDA 209686 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209686"
}
]
|
| identifier | ANDA209686 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"medications",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Clonidine |
